OTCMKTS:THERF

Theratechnologies Stock Forecast, Price & News

$3.60
0.00 (0.00 %)
(As of 04/16/2021 12:00 AM ET)
Add
Compare
Today's Range
$3.56
Now: $3.60
$3.65
50-Day Range
$3.01
MA: $3.52
$3.96
52-Week Range
$3.58
Now: $3.60
$7.29
Volume124,813 shs
Average Volume45,196 shs
Market Capitalization$277.03 million
P/E RatioN/A
Dividend YieldN/A
Beta0.58
Theratechnologies Inc., a specialty pharmaceutical company, addresses unmet medical needs to promote healthy living and improve quality of life among HIV patients. It offers EGRIFTA, for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy in Canada and the United States; and Trogarz, an injection refers to ibalizumab for the treatment of multidrug resistant HIV-1 infected patients in the United States. The company was founded in 1993 and is headquartered in Montreal, Canada.
Theratechnologies logo

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:THERF
Previous SymbolNASDAQ:THER
CUSIPN/A
CIKN/A
Phone514-336-7800
Employees32
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$45.18 million
Cash Flow$0.02 per share
Book Value$0.47 per share

Profitability

Net Income$-4,660,000.00

Miscellaneous

Market Cap$277.03 million
Next Earnings DateN/A
OptionableNot Optionable

MarketRank

Overall MarketRank

0.48 out of 5 stars

Medical Sector

1636th out of 2,024 stocks

Pharmaceutical Preparations Industry

681st out of 772 stocks

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
$3.60
0.00 (0.00 %)
(As of 04/16/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive THERF News and Ratings via Email

Sign-up to receive the latest news and ratings for THERF and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Theratechnologies (OTCMKTS:THERF) Frequently Asked Questions

What stocks does MarketBeat like better than Theratechnologies?

Wall Street analysts have given Theratechnologies a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Theratechnologies wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How were Theratechnologies' earnings last quarter?

Theratechnologies Inc (OTCMKTS:THERF) issued its quarterly earnings results on Thursday, April, 4th. The company reported $0.01 earnings per share (EPS) for the quarter, hitting the Zacks' consensus estimate of $0.01. The firm earned $15.10 million during the quarter. Theratechnologies had a negative trailing twelve-month return on equity of 14.31% and a negative net margin of 11.57%.
View Theratechnologies' earnings history
.

How has Theratechnologies' stock price been impacted by Coronavirus?

Theratechnologies' stock was trading at $2.91 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, THERF stock has increased by 23.7% and is now trading at $3.60.
View which stocks have been most impacted by COVID-19
.

Who are Theratechnologies' key executives?

Theratechnologies' management team includes the following people:
  • Mr. Luc Tanguay, Pres, CEO & Non-Independent Director (Age 61)
  • Mr. Philippe Dubuc MBA, Sr. VP & CFO (Age 52)
  • Mr. Jocelyn Lafond, VP of Legal Affairs & Corp. Sec. (Age 51)
  • Mr. Denis Boucher B.A., L.L.B., VP of Communications & Corp. Affairs (Age 53)
  • Mr. Christian Marsolais, Sr. VP & Chief Medical Officer (Age 56)

Who are some of Theratechnologies' key competitors?

What is Theratechnologies' stock symbol?

Theratechnologies trades on the OTCMKTS under the ticker symbol "THERF."

How do I buy shares of Theratechnologies?

Shares of THERF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Theratechnologies' stock price today?

One share of THERF stock can currently be purchased for approximately $3.60.

How much money does Theratechnologies make?

Theratechnologies has a market capitalization of $277.03 million and generates $45.18 million in revenue each year.

How many employees does Theratechnologies have?

Theratechnologies employs 32 workers across the globe.

What is Theratechnologies' official website?

The official website for Theratechnologies is www.theratech.com.

Where are Theratechnologies' headquarters?

Theratechnologies is headquartered at 2015 Peel Street 5th Floor, MONTREAL A8, H3A 1T8.

How can I contact Theratechnologies?

Theratechnologies' mailing address is 2015 Peel Street 5th Floor, MONTREAL A8, H3A 1T8. The company can be reached via phone at 514-336-7800 or via email at [email protected]


This page was last updated on 4/18/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected]at.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.